课题基金 / 基金详情

REGULATABLE GENE TRANSFER SYSTEM

REGULATABLE GENE TRANSFER SYSTEM
可调节基因转移系统
批准号:
6501124
负责人:
SOPHIA Y. TSAI
金额:
$12.63万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-01 至 2002-08-31

项目摘要

项目成果

SOPHIA Y. TSAI的其他基金

相似基金

相关文献

中文摘要
翻译
人LDL受体主要在肝脏中表达,其功能是 清除血液循环中的LDL和胆固醇。LDL突变 受体已显示引起高胆固醇血症, 心血管疾病和心肌梗塞的早期症状。的 这个项目的目标是使用一个诱导系统, 转基因小鼠肝脏的人LDL受体以及研究 使用腺病毒载体递送这种诱导系统的功效 细胞培养。诱导系统由嵌合的 转录调节子GLVP和含有结合的靶基因 监管机构认可的网站。在诱导剂RU 486的存在下, 该调节剂结合并激活靶基因表达。这种诱导性 系统先前已被证明可以有效地诱导 各种靶基因在细胞培养物和转基因小鼠中的表达 到5000倍。为了研究人LDL受体的受控表达, 我们建议:1)。产生含有以下的转基因小鼠靶系: 人LDL受体cDNA; 2).产生双转基因小鼠品系, 响应外源配体表达人LDL受体; 3). 通过将病毒激活结构域用一个 从人转录因子激活结构域,以促进 该诱导系统在基因治疗中的未来应用; 4). 使用诱导表达的LDL受体在培养的细胞中, 腺病毒递送系统。这些研究对我们提供 血清LDL受体表达和清除重要动力学数据 LDL和胆固醇。我们希望调查结果 将使我们能够制定更好的协议,为未来的人类基因 高胆固醇血症和其他心血管疾病的治疗研究。
英文摘要
Human LDL receptor is expressed primarily in the liver and functions to clear the LDL and cholesterol from the circulation. Mutations of the LDL receptor have been shown to cause hypercholesterolemia which often results in cardiovascular diseases and myocardial infarction at an early age. The goal of this project is to use an inducible system to specifically target the human LDL receptor to the liver in transgenic mice as well as to study the efficacy of using adenoviral vector to deliver this inducible system into cell culture. The inducible system consists of a chimeric transcriptional regulator GLVP and a target gene containing the binding sites recognized by the regulator. In the presence of an inducer, RU486, the regulator binds and activates target gene expression. This inducible system has previously been demonstrated to effectively induce the expression of various target genes in cell culture and transgenic mice up to 5000-fold. To investigate controlled expression of human LDL receptor, we propose to: 1). Generate transgenic mouse target lines containing the human LDL receptor- cDNA; 2). Generate bitransgenic mouse lines capable of expressing the human LDL receptor in response to exogenous ligand; 3). Modify the regulator by substituting the viral activation domain with an activation domain from a human transcription factor to facilitate the future application of this inducible system for gene therapy; 4). Inducible expression of the LDL receptor in cultured cells using adenoviral delivery system. These studies are crucial in providing us with important kinetic data on LDL receptor expression and clearance of serum LDL and cholesterol. We expect that the results from this investigation shall enable us to formulate better protocols for future human gene therapy study in hypercholesterolemia and other cardiovascular diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nuclear Orphan Receptor, COUP-TFII, in Energy Metabolism and Disease
  • 批准号:
    8701374
  • 项目类别:
  • 资助金额:
    $38.34万
  • 财政年份:
    2013
  • 负责人:
    SOPHIA Y. TSAI
  • 依托单位:
Nuclear Orphan Receptor, COUP-TFII, in Energy Metabolism and Disease
  • 批准号:
    8495646
  • 项目类别:
  • 资助金额:
    $37.25万
  • 财政年份:
    2013
  • 负责人:
    SOPHIA Y. TSAI
  • 依托单位:
ORPHAN RECEPTOR COUP-TFII IN ADIPOCYTE DIFFERENTIATION
  • 批准号:
    7477174
  • 项目类别:
  • 资助金额:
    $34.96万
  • 财政年份:
    2007
  • 负责人:
    SOPHIA Y. TSAI
  • 依托单位:
ORPHAN RECEPTOR COUP-TFII IN ADIPOCYTE DIFFERENTIATION
  • 批准号:
    7215497
  • 项目类别:
  • 资助金额:
    $24.0万
  • 财政年份:
    2006
  • 负责人:
    SOPHIA Y. TSAI
  • 依托单位:
海外基金